AI-Native Discovery in Pharma - with Alister Campbell of Dotmatics

Today's guest is Alister Campbell, Vice President, Global Head of Science and Technology at Dotmatics. Campbell works at the intersection of scientific R&D, data strategy, and applied AI across the drug discovery lifecycle. Alister joins Emerj Client Narrative & Content Strategy Lead Nick Gertsch to discuss how data and AI are shifting pharma R&D from linear, empirical workflows toward tighter, more predictive discovery loops where experiments, simulation, and modeling inform decisions earlier and faster. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!